BioScrip, Inc.Elmsford, NY, United States (NASDAQ (GM): BIOS)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

BioScrip Financial Statements

BioScrip Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

BioScrip Income Statement

  2007 2006 2005
Revenue ($ mil.) 1,197.7 1,152.5 1,073.2
Gross Profit ($ mil.) 137.0 119.6 116.3
Operating Income ($ mil.) 8.9 (16.2) (29.2)
Total Net Income ($ mil.) 3.3 (38.3) (23.9)
Diluted EPS (Net Income) 0.09 (1.03) (0.70)
More BioScrip financial information

BioScrip Quarterly Statements

  Quarter Ending Jun 08 Quarter Ending Mar 08 Quarter Ending Dec 07
Revenue ($ mil.) 348.4 327.5 308.3
Gross Profit ($ mil.) 35.7 32.4 35.1
Operating Income ($ mil.) 3.4 0.2 3.1
Total Net Income ($ mil.) 1.6 (0.5) 2.5
Diluted EPS (Net Income) 0.04 (0.01) 0.07
More BioScrip financial information

BioScrip Financial Ratios

  Company Industry
Median
Market
Median1
Price/Sales Ratio 0.08 0.34 1.05
Price/Earnings Ratio 19.57 12.67 11.14
Price/Book Ratio 0.62 1.19 0.99
Price/Cash Flow Ratio 3.58 5.39 6.53
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed BioScrip Financial Ratios

BioScrip Competitive Intelligence

AmerisourceBergen CVS Caremark Medco Health
Annual Sales ($ mil.) 66,074.3 76,329.5 44,506.2
Employees 11,300 200,000 20,800
Market Cap ($ mil.) 4,788.3 42,914.2 19,215.7

Competitive Landscape